Serum Institute of India

Serum Institute of India CEO Adar Poonawalla said the company plans to launch its indigenously-developed vaccine to treat cervical cancer in women later this year. The Drugs Controller General of India (DCGI) on Tuesday granted market…
Read More...

Bengaluru: Serum Institute of India CEO Adar Poonawalla on Friday said that it was unethical to start giving the third booster dose of Covid vaccine to someone when others in certain countries and populations have not even got two doses for…
Read More...

London: The Chief executive of Serum Institute of India (SII), Adar Poonawalla agreed to rent a property for about $69,000(Rs 50 Lakh) a week, in London’s exclusive Mayfair area. Adar Poonawalla  is leasing the home on one of the…
Read More...

Pune: A major fire broke out at Serum Institute of India (SII) in Pune in Maharashtra today. While the exact reason behind the fire is yet to be known, it is suspected that the inferno might have been caused due to a short-circuit.…
Read More...

New Delhi: The Drug Controller General of India (DCGI) V.G. Somani on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use, paving the way for their roll-out and administration to…
Read More...

Bhubaneswar: Serum Institute of India (SII) CEO Adar Poonawalla claims that Coronavirus vaccination is likely to begin in India by January and by October all the countrymen can return to their normal lives. He said that his firm  is…
Read More...

New Delhi: Covaxin, the COVID vaccine candidate by Hyderabad-based vaccine manufacturer Bharat Biotech Limited, being developed in collaboration with the Indian Council of Medical Research (ICMR), is likely to be available for use of the…
Read More...

Bhubaneswar: Adar Poonawala, Chief Executive Officer (CEO) of Serum Institute of India said that a safe and effective vaccine against COVID-19 may be likely available in India by January 2021. The Serum Institute of India(SII) is in…
Read More...

Bhubaneswar/New-Delhi : Serum Institute of India's CEO Adar Poonawalla has warned there won’t be enough Covid-19 vaccines available in the world till 2024 end. "It  will take at least four years to make enough Covid-19 vaccines for the…
Read More...

New Delhi: The Drugs Controller General of India (DCGI) has given approval to Pune's Serum Institute of India (SII) to conduct clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine in India. The SII received approval by the…
Read More...